Medthority

Medthority Get closer to the conversations that matter in medicine, with our award-winning medical education platform.

From podcast episodes to videos and articles, our channel showcases the latest resources on medthority.com

This  , browse our Oncology Hub for the latest advances and congress highlights in genitourinary, respiratory, and sarco...
04/02/2026

This , browse our Oncology Hub for the latest advances and congress highlights in genitourinary, respiratory, and sarcoma oncology, from assessing patient risk of disease recurrence to identifying unmet needs

https://ow.ly/PeYu50Y8SJ5

  starts today! Don't forget you can still earn 1 CME credit with our on-demand recording on late onset Pompe disease (L...
02/02/2026

starts today! Don't forget you can still earn 1 CME credit with our on-demand recording on late onset Pompe disease (LOPD), covering patient insights on overlooked symptoms and unmet needs. Click the link below to earn your CME credit now 🔗

https://ow.ly/44Wn50Y7tj2

30/01/2026

How can we mitigate potential risks in non-muscle-invasive bladder cancer (NMIBC) treatment? Morgan Rouprêt shares his thoughts at , including incorporating pathological assessment into treatment selection. For more congress highlights and the latest trial data, head to Medthority now

https://ow.ly/xJS450Y5WTJ

New research has uncovered the pathway that causes uncontrolled inflammation in obesity, plus messenger RNA in the uteru...
29/01/2026

New research has uncovered the pathway that causes uncontrolled inflammation in obesity, plus messenger RNA in the uterus cell lining might lead to future treatments for some forms of infertility. Get the latest medical news on Medthority

https://ow.ly/EpUX50Y4Ky0

Only 1 month to go until  ! Get ready with a quick recap on key prostate cancer highlights from   on Medthority, includi...
28/01/2026

Only 1 month to go until ! Get ready with a quick recap on key prostate cancer highlights from on Medthority, including expert insights on a new treatment option for HRR-deficient mCRPC and our posters round-up

https://ow.ly/MHk250Y4K0E

What can primary care providers do to support earlier diagnosis of alpha-1 antitrypsin deficiency (AATD)-associated live...
26/01/2026

What can primary care providers do to support earlier diagnosis of alpha-1 antitrypsin deficiency (AATD)-associated liver disease? Watch James Stoller challenge common misconceptions about the diagnostic process and highlight gaps in medical education that impact real-world practice

https://ow.ly/M0uO50Y3Oo6

Tomorrow is  ! Even if you only have 10 minutes to spare, get the latest updates in your field with Medthority's indepen...
23/01/2026

Tomorrow is ! Even if you only have 10 minutes to spare, get the latest updates in your field with Medthority's independent resources. You can browse by therapy area using the link to our Speciality Hub below

https://ow.ly/QMpN50Y1Ctc

� New research validates the electronic health record cancer-associated thrombosis (EHR-CAT) score for more accurate ris...
22/01/2026

� New research validates the electronic health record cancer-associated thrombosis (EHR-CAT) score for more accurate risk classification, supporting scalable, EHR-driven VTE assessment in routine oncology practice. Read our latest news article from our expert scientific team at the link below

https://ow.ly/TL9N50Y1ej8

Have you watched our on-demand roundtable covering insights from 2025 thrombosis trial data? From reduced-dose anticoagu...
21/01/2026

Have you watched our on-demand roundtable covering insights from 2025 thrombosis trial data? From reduced-dose anticoagulation strategies to evolving approaches in atrial fibrillation and venous thromboembolism, stay ahead in thrombosis care with Medthority

https://ow.ly/Lmfo50Y0Bin

From alopecia and psoriasis to hidradenitis suppurativa and urticaria, check out our Dermatology Hub for podcasts, quizz...
20/01/2026

From alopecia and psoriasis to hidradenitis suppurativa and urticaria, check out our Dermatology Hub for podcasts, quizzes, roundtables, and many more expert resources designed to support your clinical practice. Click the link below to access now 🔗

https://ow.ly/ZIW850XZXVI

As the treatment landscape for high-risk non-muscle-invasive bladder cancer (NMIBC) continues to evolve, get the expert ...
19/01/2026

As the treatment landscape for high-risk non-muscle-invasive bladder cancer (NMIBC) continues to evolve, get the expert insights you need to know with our Managing High-Risk NMIBC Learning Zone. Log in now to:

👩‍💻Watch expert discussions from Joshua Meeks, MD, PhD, and Félix Guerrero-Ramos, MD, PhD, FEBU on the future of NMIBC trials and cultural differences in patient experiences

🔑Stay up to date with the key congress highlights from 2025 with interviews and summary articles from , , , and

🎧Listen to Ashish Kamat, MD, MBBS, FACS, and guests in our podcast series, Expert voices - Navigating NMIBC, for the latest bladder cancer updates on the go

Inform your clinical practice with on-demand resources designed to equip you with the information you need on NMIBC care. Click the link below now 🔗

https://ow.ly/Iwhf50XZyN0

Help us continue to improve medical education in 2026 by taking our quick survey! If you have 5 minutes, share your insi...
16/01/2026

Help us continue to improve medical education in 2026 by taking our quick survey! If you have 5 minutes, share your insights with us today and help shape the future of learning for healthcare professionals worldwide 🌍

https://ow.ly/C4wK50XXToj

Address

6 Vale Avenue
Tunbridge Wells
TN11DJ

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 8am - 5:30pm
Friday 9am - 5:30pm

Telephone

+441892577706

Alerts

Be the first to know and let us send you an email when Medthority posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram